Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Hong

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
BMC Research Notes|May 9, 2015
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data qualityGerald B Fogarty, Angela Hong, Kari Dolven-Jacobsen, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
Cancer Medicine|February 18, 2022
Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature reviewElizabeth A Connolly, Vivek A Bhadri, Johnathon Wake, et al.
World Neurosurgery|July 24, 2017
Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of LesionsMir Amaan Ali, Brian R Hirshman, Bayard Wilson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 7, 2016
In-Transit Metastasis From Squamous Cell CarcinomaJoyce H Y Ma, Albert Wu, Michael Veness, et al.
Journal for Immunotherapy of Cancer|March 8, 2023
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapyPrachi Bhave, Angela Hong, Serigne N Lo, et al.
Canadian Journal of Kidney Health and Disease|July 22, 2021
Incidence and Outcomes of Acute Kidney Injury in Patients Admitted to Hospital With COVID-19: A Retrospective Cohort StudyTyler Pitre, Angela Hong Tian Dong, Aaron Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2025
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective studyMario Mandalà, Teresa Amaral, Piotr Rutkowski, et al.
Cancer Immunology Research|March 6, 2021
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient SurvivalNicholas A Gherardin, Kelly Waldeck, Alex Caneborg, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
BMC Research Notes|May 9, 2015
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data qualityGerald B Fogarty, Angela Hong, Kari Dolven-Jacobsen, et al.
The Lancet. Oncology|May 12, 2012
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBryan H Burmeister, Michael A Henderson, Jill Ainslie, et al.
The Lancet. Oncology|July 25, 2015
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trialMichael A Henderson, Bryan H Burmeister, Jill Ainslie, et al.
Cancer Medicine|February 18, 2022
Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature reviewElizabeth A Connolly, Vivek A Bhadri, Johnathon Wake, et al.
World Neurosurgery|July 24, 2017
Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of LesionsMir Amaan Ali, Brian R Hirshman, Bayard Wilson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 7, 2016
In-Transit Metastasis From Squamous Cell CarcinomaJoyce H Y Ma, Albert Wu, Michael Veness, et al.
Journal for Immunotherapy of Cancer|March 8, 2023
Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapyPrachi Bhave, Angela Hong, Serigne N Lo, et al.
Canadian Journal of Kidney Health and Disease|July 22, 2021
Incidence and Outcomes of Acute Kidney Injury in Patients Admitted to Hospital With COVID-19: A Retrospective Cohort StudyTyler Pitre, Angela Hong Tian Dong, Aaron Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2025
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective studyMario Mandalà, Teresa Amaral, Piotr Rutkowski, et al.
Cancer Immunology Research|March 6, 2021
γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient SurvivalNicholas A Gherardin, Kelly Waldeck, Alex Caneborg, et al.
Pageof 8